Antibiotic treatment of bacterial vaginosis in pregnancy: A meta-analysis

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 3, 2003, Pages 752-758

  Leitich, Harald ^a   Brunbauer, Mathias ^a   Bodner Adler, Barbara ^a   Kaider, Alexandra ^a   Egarter, Christian ^a   Husslein, Peter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antibiotic treatment; Bacterial vaginosis; Meta analysis; Preterm delivery

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; METRONIDAZOLE; PLACEBO;

AMNION; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; NEISSERIA GONORRHOEAE; NEWBORN DEATH; NEWBORN MORBIDITY; PERINATAL DEATH; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREPONEMA PALLIDUM; TRICHOMONAS VAGINALIS; VAGINITIS;

EID: 0037342226     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.167     Document Type: Article

References (33)

1. Amsel R, Totten PA, Spiegel CA, Chen KSC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbiologic and epidemiologic associations. Am J Med 1983;74:14-22.
2. Eschenbach DA. History and review of bacterial vaginosis. Am J Obstet Gynecol 1993;169:441-5.
3. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-7.
4. Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract 1999;48:885-92.
5. McGregor JA. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000;55(Suppl):S1-19.
6. Hauth JC, Goldenberg RE, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
7. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997;104:1391-7.
8. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994;171:345-9.
9. Brocklehurst P, Hannah M, McDonald H. Interventions for treating bacterial vaginosis in pregnancy (Cochrane Review). Cochrane Library, Issue 1, Oxford: Update Software; 2002.
10. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000;342:534-40.
11. Guise JM, Mahon SM, Aickin M, Helfand M, Peipert JF, Westhoff C. Screening for bacterial vaginosis in pregnancy. Am J Prev Med 2001;20:62-72.
12. The U.S. Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy: recommendations and rationale. Am J Prev Med 2001;20:59-61.
13. American College of Obstetricians and Gynecologists. Assessment of risk factors for preterm birth. Washington (DC): American College of Obstetricians and Gynecologists; 2001. Practice bulletin No.: 31.
14. Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987;6:341-8.
15. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991;10:1665-77.
16. Joesoef MR, Hiller SL, Wiknjosastro G, Sumampouw H, Linnan M, Norojono W, et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527-31.
17. Kekki M, Kurki T, Pelkonen J, Kurkinen-Räty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001;97:643-8.
18. Kurkinen-Räty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J, et al. A randomized controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. Br J Obstet Gynaecol 2000;107:1427-32.
19. McGregor JA, French JI, Seo K. Adjunctive clindamycin therapy for preterm labor: results of a double-blind, placebo-controlled trial. Am J Obstet Gynecol 1991;165:867-75.
20. McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170:1048-60.
21. Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomized placebo-controlled double-blind trial. Br J Obstet Gynaecol 1999;106:652-7.
22. Duff P, Lee ML, Hillier SL, Herd LM, Krohn MA, Eschenbach DA. Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet Gynecol 1991;77:431-5.
23. McGregor JA, French JI, Richter R, Vuchetich M, Bachus V, Seo K, et al. Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol 1990;163:1580-91.
24. Newton ER, Dinsmoor MJ, Gibbs RS. A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labor. Obstet Gynecol 1989;74:562-6.
25. Newton ER, Shields L, Ridgway LE III, Berkus MD, Elliott BD. Combination antibiotics and indomethacin in idiopathic preterm labor: a randomized double-blind clinical trial. Am J Obstet Gynecol 1991;165:1753-9.
26. Vermeulen GM, van Zwet AA, Bruinse HW. Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth. Br J Obstet Gynaecol 2001;108:697-700.
27. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308:295-8.
28. Kurki T, Sivonen A, Renkonen O-V, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173-7.
29. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, et al. The preterm prediction study: risk factors in twin gestations. Am J Obstet Gynecol 1996;175:1047-53.
30. Wennerholm U-B, Holm B, Mattsby-Baltzer I, Nielsen T, Platz-Christensen JJ, Sundell G, et al. Interleukin-lα, interleukin-6 and interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin gestation. Acta Obstet Gynecol Scand 1998;77:508-14.
31. Goldenberg RL, Klebanoff M, Carey JC, MacPherson C, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Metronidazole treatment of women with a positive fetal fibronectin test result. Am J Obstet Gynecol 2001;185:485-6.
32. Nugent RP, Krobn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
33. Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid. J Clin Microbiol 1983;18:170-7.